Respiratory care is a health specialty that provides diagnostic evaluation, management, control, therapy, and monitoring of respiratory diseases and disorders. Typically, the market players focus on specific product segments such as therapeutics, monitoring, and diagnostics. This has created market leaders in various product segments. Covidien plc (Ireland) and Masimo Corporation (U.S.) are the leading players in the respiratory monitoring devices market, owing to their highly established range of pulse oximeters. Philips Healthcare (Netherlands) and ResMed, Inc. (U.S.) dominate the therapeutic devices segment. The Asia-Pacific market is offering lucrative growth opportunities which is increasing competition among market players in terms of capturing a larger market share in this under-penetrated regional segment. The companies are also focusing on R&D to add innovative technologies and products to their portfolios, which in turn helps them to strengthen their presence in the respective markets.

Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=368

Philips Healthcare’s leading position in this market is mainly attributed to its broad product portfolio with major focus on respiratory care therapeutic devices. The company has a significant global footprint owing to its strong sales and distribution network. It significantly invests in R&D activities to add innovative technologies and products to its portfolio, which in turn helps it to strengthen its presence in the market. With a strong portfolio of respiratory products and incessant efforts to develop innovative products, the company is likely to maintain its strong position in the market.

ResMed, Inc. is another leading company in the global respiratory care market with a wide geographical presence across North America, Asia-Pacific, and Europe. It is well-positioned in the respiratory market and focuses on developing new and innovative products. In accordance with this, over the last five years, the company has developed and launched several respiratory care products at regular intervals.

Covidien plc has a broad product portfolio of ventilators and pulse oximeters and a wide geographical presence with distribution channels in around 70 countries, which enables it to reach out to a fragmented customer base. The company is a global leader in the pulse oximeters market. It pursues the strategy of new product launches in order to strengthen its share in the respiratory care devices market. It is also rigorously aiming at expanding its R&D capabilities in order to develop technologically advanced products and to cater to the changing customer needs.

Apart from the above three, other players with a significant presence in the respiratory care devices market include Masimo Corporation (U.S.), Fisher and Paykel Healthcare Limited (New Zealand), CareFusion Corporation (U.S.), Invacare Corporation (U.S.), and Chart Industries, Inc. (U.S.). Owing to the technological competitiveness of the market, all the players in this market focus on innovation as their key growth strategy, and aim to strengthen their market presence with the launch of technologically superior products, catering to the needs of various end-user segments.